ストックスクリーナーアプリを入手
18.90
1.20%
-0.23
アフターアワーズ：
18.86
-0.04
-0.21%
Kenvue Inc (KVUE) 最新ニュース
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - The Joplin Globe
Levin Capital Strategies L.P. Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
Kenvue broadens China focus on minor ailment management - China Daily Global Edition
What to expect from Kenvue’s Q2 2026 earnings report - MSN
KBC Group NV Increases Holdings in Kenvue Inc. $KVUE - MarketBeat
SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE - MarketBeat
The Listerine Cool Mint MouthwashKenvue bets on bold flavor and plaque control - Ad-hoc-news.de
Kenvue stock steadies as consumer health margins lift earnings outlook - Ad-hoc-news.de
Listerine Cool Mint by Kenvuemouthwash mainstay keeps mint segment humming - Ad-hoc-news.de
Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating - marketscreener.com
What to Expect From Kenvue’s Q2 2026 Earnings Report - Inkl
Kenvue Inc. $KVUE Shares Sold by Kapitalo Investimentos Ltda - MarketBeat
Swiss National Bank Has $96.94 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health spin-off builds earnings record - Ad-hoc-news.de
Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Kenvue Inc. $KVUE Stake Lifted by Hsbc Holdings PLC - MarketBeat
California Public Employees Retirement System Decreases Stake in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady as the latest report frames 2026 margins - Ad-hoc-news.de
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report? - The Motley Fool
Bank of New York Mellon Corp Sells 223,497 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins hold after spin-off - ad-hoc-news.de
Listerine Cool Mint by Kenvue Inc.mouthwash classic fuels recurring sales - ad-hoc-news.de
Illinois Municipal Retirement Fund Buys 72,348 Shares of Kenvue Inc. $KVUE - MarketBeat
How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story - simplywall.st
Kenvue stock trades steadily as consumer health margins stay in focus - ad-hoc-news.de
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
KVUE Maintained by UBS -- Price Target Raised to $20.00 - GuruFocus
Diversify Wealth Management LLC Buys New Stake in Kenvue Inc. $KVUE - MarketBeat
Blackhawk Capital Partners LLC Invests $1.66 Million in Kenvue Inc. $KVUE - MarketBeat
Daily Brief Consumer: Colowide Co Ltd, Seven & I Holdings, Alibaba, New Hope Dairy Co Ltd, Global Education Communities C, Kenvue , Netflix Inc, Shadowfax Technologies, Suminoe Textile, Tailored Brands and more - Smartkarma
Neutrogena® announces 'Break the Rules' to break beauty's rules with scienceA new view of care - Kenvue
Kenvue stock holds steady as investors wait for the next catalyst - ad-hoc-news.de
Fifth Third Bancorp Grows Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Filippo Falorni Reiterates Hold on Kenvue, Keeps Price Target Unchanged at $19 Amid Renewed Tylenol Litigation Risks - TipRanks
US appeals court revives hundreds of private lawsuits linking Tylenol to autism - Reuters
Update: Kenvue Must Face Claims Linking Tylenol to Autism, Appeals Court Says - Moomoo
Calamos Advisors LLC Acquires 651,000 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue/Kimberly-Clark Deal Not in Jeopardy Despite Tylenol Ruling -- Market Talk - Moomoo
Second Circuit Court of Appeals Ruling - Kenvue
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Kenvue's Tylenol Liability Nightmare: Appeals Court Reversal Ignites Fresh Legal Battle - Kavout | AI
U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims - The Globe and Mail
KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits - Stocktwits
Kenvue faces revived Tylenol autism lawsuits after U.S. appeals court ruling - Traders Union
Tylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Says - Bloomberg.com
Tylenol-Maker Kenvue Must Face Autism Lawsuits, Court Says (2) - Bloomberg Law News
Kenvue options trading climbs to over 16,000 contracts By Investing.com - Investing.com Nigeria
Kenvue (KVUE) Shares Surge After Favorable Court Ruling - GuruFocus
Kenvue options trading climbs to over 16,000 contracts - Investing.com UK
Kenvue stock falls after court revives autism lawsuits By Investing.com - Investing.com Nigeria
US Appeals court revives lawsuits linking Tylenol-maker Kenvue to autism (update) (KVUE:NYSE) - Seeking Alpha
Kenvue stock falls after court revives autism lawsuits - Investing.com
Kenvue stock steadies as investors weigh its consumer brands - ad-hoc-news.de
Kenvue (NYSE:KVUE) Rating Increased to Buy at Wall Street Zen - MarketBeat
1.44%
大文字化:
|
ボリューム (24 時間):